0001171843-20-001364.txt : 20200227 0001171843-20-001364.hdr.sgml : 20200227 20200227185444 ACCESSION NUMBER: 0001171843-20-001364 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200225 FILED AS OF DATE: 20200227 DATE AS OF CHANGE: 20200227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAND RAYMOND J CENTRAL INDEX KEY: 0001225613 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 20664688 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 ownership.xml X0306 4 2020-02-25 0 0000898437 Anika Therapeutics, Inc. ANIK 0001225613 LAND RAYMOND J 32 WIGGINS AVENUE BEDFORD MA 01730 1 0 0 0 Common Stock 2020-02-25 4 A 0 4107 0 A 16099 D Common Stock 2020-02-26 4 S 0 2700 42.68 D 13399 D These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 25, 2021. On February 26, 2020, Mr. Land sold 2,700 shares in multiple trades ranging from $42.53 to $42.80. The price reported above reflects the weighted average sales price. Mr. Land undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected. /s/ Raymond J. Land 2020-02-27